Natural History of Bronchiectasis

  • STATUS
    Recruiting
  • participants needed
    900
  • sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
Updated on 15 September 2021
ct scan
pulmonary function test
x-rays
pulmonary disease
cystic fibrosis
respiratory infections
respiratory symptom
pulmonary function tests
lung disease
fibrosis
bronchiectasis
genetic testing
genetic tests
allergic bronchopulmonary aspergillosis

Summary

Background
  • Bronchiectasis is a disease characterized by airways that are inflamed, abnormally dilated, and chronically infected. Individuals with bronchiectasis have a history of chronic and recurring respiratory infections. Depending on the underlying cause, these infections may involve the entire respiratory tract, resulting in sinus, ear, and lung disease.
  • Bronchiectasis continues to be a significant problem in developing countries and in specific groups of individuals, particularly in people who have cystic fibrosis. Although treatments are available or under development for bronchiectasis related to cystic fibrosis, many of the disease-specific treatments may not be effective for bronchiectasis not related to cystic fibrosis.
    Objectives
  • To study the natural history of bronchiectasis to identify inherited and immune factors that may explain why certain individuals have chronic recurring infections.
    Eligibility
  • Individuals 5 years of age and older who have an established diagnosis of bronchiectasis or a history of chronic/recurring respiratory infections.
  • Direct family members (e.g., parents, siblings, children) of patients in the study may also be asked to participate.
    Design
  • Potential participants will be screened with an initial clinic evaluation and full medical history, as well as a general quality of life and respiratory symptom questionnaire.
  • The following standard procedures may be done as part of the study: air sampling from the nose; imaging studies, which may include an x-ray or computed tomography (CT), lung function tests; and collection of samples of blood, urine, and sputum (phlegm or mucus). Other tests may be performed as required by the researchers, and will be explained to patients as needed.
  • Both patients and relatives (if asked to participate) will provide the following samples: blood or buccal (cheek swab) cells for genetic testing, sputum, and urine.
  • To prevent infections and potential disease progression, patients may receive standard medical care and treatment for bronchiectasis and related infections during this protocol.

Description

Bronchiectasis, or abnormal dilation of the airways, is a condition typically characterized by chronic and recurring respiratory tract infections. Frequently, depending on the underlying cause, these infections involve the entire respiratory tract resulting in sinus, ear, and lung disease. This condition used to be more common in children prior to immunizations for childhood infections. It continues to be a significant problem in developing countries and in specific groups of individuals in the U.S. Cystic fibrosis (CF) is the most commonly associated genetic condition and tremendous strides have been made in recent years in understanding the mechanisms of this disease that are leading to a multitude of emerging novel treatment strategies. The mechanisms of other causes for bronchiectasis have not evolved to this degree, and many of the disease-specific treatments being assessed for cystic fibrosis may not be effective for non-CF bronchiectasis. Often bronchiectasis can be associated with chronic infections from environmental germs such as the nontuberculous mycobacteria.

Details
Condition Pulmonary Disease, Cystic Fibrosis, Immunodeficiency, Bronchiectasis, Pancreatic disorder, Autoimmune disease, Autoimmunity, Common Variable Immunodeficiency, Pancreatic Disorders, Common Variable Immunodeficiency (CVID), Primary Immunodeficiency Disorders, Lung Disease, autoimmune diseases, autoimmune disorder, autoimmune disorders
Clinical Study IdentifierNCT00943514
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Last Modified on15 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Children age 5 years and above and adults referred to the NIH with chronic or recurring respiratory infections will be eligible for participation
Males and females will be considered without regard to race or ethnicity or upper age limit
Emphasis will be primarily on non CF bronchiectasis for elucidation of mechanisms of infection susceptibility. However, select patients with cystic fibrosis or acquired immune defects (such as HIV) may be studied if relevant host defects are suspected or if needed for comparison purposes or to evaluate and study the management of chronic pathogen associated conditions such as nontuberculous mycobacterial infections or allergic bronchopulmonary aspergillosis
Subjects must have a primary or referring physician
Subjects must be willing to have samples stored
INCLUSION CRITERIA FOR RELATIVES
As a part of this protocol we may obtain blood, sputum, urine, or buccal swabs
from some blood relatives of patients on the study, with the hope of isolating
and characterizing the primary host defense defect(s) or genetic links
responsible for airway infection susceptibility and/or bronchiectasis seen
within families. Male and female relatives will be accepted without limitation
due to age. These relatives may have pertinent disease-related history
obtained, but will neither receive treatment nor have any other protocol
procedures done unless they are enrolled on the study

Exclusion Criteria

We wish to avoid enrolling subjects, especially children, who have common respiratory problems (aeroallergen sensitivity, asthma, gastric esophageal reflux) that are not associated with an underlying abnormality in host defenses. Evidence of significance of chronic or recurring infections suggestive of an underlying airway surface or systemic host defense defect should be documented by one or more of the following: a) sinus or lower airway cultures positive for bacterial, fungal, or mycobacterial pathogens characteristic of these defects; or b) radiographic evidence of sinusitis with mucosal thickening and/or air-fluid levels; or c) radiographic evidence of bronchiectasis; d) severity of otitis media requiring placement of tympanic membrane pressure equalization tubes; e) severity of sinusitis requiring surgical intervention
Patients who are unable or unwilling to provide informed consent either directly or via appropriately designated surrogate
Any patient who, in the opinion of the Investigator, is unable or unwilling to comply with regular follow-up or is unlikely to provide pertinent information regarding disease progression or response to treatment may be excluded from longitudinal follow-up
Children under the age of 5 will be excluded from this protocol
When a pediatric subject reaches age 18, continued participation will require
reconsenting with the adult consent document
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note